SickleFit Exercise and Nutrition Study
The SickleFit Exercise and Nutrition Randomized Control Trial for Older Adults With Sickle Cell Disease
Who can join
As published by the study on ClinicalTrials.gov. "Not stated" means the study hasn't said — ask the study team.
- Age
- 35 Years and older
- Sex
- All sexes
- Healthy volunteers
- Not accepted
- Compensation
- Not stated
Other requirements are listed under Eligibility below. Only the study team can confirm whether you can join.
What to expect
No one can promise a trial will help you personally — that is what the research is trying to find out.
What participation involves
Not stated in the study description — ask the study team about visits and procedures.
- Compensation
- Not stated
- Study-related exams and procedures are typically provided at no cost. This is how many trials work in general — confirm the details for this study with the study team.
- Participants are monitored closely by the research team throughout the study.
- Some participants may receive access to an investigational treatment, which is still being studied.
- Your participation helps researchers learn whether this approach could help future patients.
About this study
In plain language
This study tests SickleFit, an exercise and nutrition program for adults with sickle cell disease. It is for people age 35 or older. Participants are placed into study groups by chance.
To goal of this study is to pilot the SickleFit exercise and nutrition intervention in adults with sickle cell disease in a randomized control trial
Compensation is read from the study's own description and may be missing — always confirm with the study team.
Eligibility
Who can join
- Have sickle cell disease of any type, confirmed by a lab test.
- Say that you can understand and speak English.
- Be age 35 or older.
Who can't join
- Depend on extra oxygen to breathe.
- Have a heart condition that is not stable.
- Need a wheelchair to get around.
- Have severe problems with thinking or memory, documented in medical records or reported by your care provider.
- Cannot give your own consent to join the study.
- Have severe vision or hearing problems that have not been corrected.
- Are pregnant.
- Have had successful treatment for sickle cell disease with a stem cell transplant (blood-forming cells) or gene therapy (treatment that changes genes).
Simplified for readability. The official criteria below are what the study team uses.
Official eligibility criteria
Inclusion Criteria: * Laboratory-confirmed diagnosis of sickle cell disease (any genotype) * Understand and speak English by self-report * Age ≥ 35 years old Exclusion Criteria: * Oxygen dependence * Unstable cardiac disease * Wheelchair-bound * Diagnosed with severe cognitive impairment based on ICD-10 codes or reported by their outpatient provider * Unable to self-consent * Severe uncorrected visual or auditory impairment * Pregnant * Successfully treated with hematopoietic stem cell transplantation or gene therapy for sickle cell disease
Study sites (1)
NC
- Duke University · Durham, NC 27710Teagan Callaway · Study contact · 919-684-0628 · teagan.callaway@duke.eduRania Mohamed · Study contact · rania.mohamed@duke.eduCharity I Oyedeji, MD · Principal investigatorJohn J Strouse, MD PhD · Sub-investigatorMore trials in Durham